| Description | 1
Day Price Change %  | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | 0.22 | 1834.1B | 62.21 | 11.48 | 2.21 | NA | 9.26 | 10.96 | 103.31 |
| Industry: Drug Manufacturers - Major (More Info) | 0.03 | 901.0B | 18.30 | 15.40 | 3.56 | NA | 10.61 | 15.90 | 157.70 |
| Companies | |||||||||
| Tetragenex Pharmaceuticals, In (TTRX.OB) | -40.00 | 0.5M | NA | NA | NA | NA | NA | NA | 1.84 |
| Winston Pharmaceuticals, Inc. (WPHM.OB) | -40.00 | 33.3M | NA | NA | NA | NA | 20.00 | -167.68 | -36.46 |
| iBio, Inc. (IBPM.OB) | -16.16 | 23.2M | NA | NA | NA | NA | 4.42 | NA | -112.73 |
| GeoPharma Inc. (GORX) | -7.69 | 11.6M | NA | -53.74 | NA | NA | 1.75 | -73.18 | 4.24 |
| WuXi PharmaTech (Cayman) Inc. (WX) | -2.53 | 944.1M | NA | -5.16 | NA | NA | 3.82 | 21.93 | NA |
| Myriad Pharmaceuticals, Inc. (MYRX) | -2.50 | 131.5M | NA | -73.46 | NA | NA | 0.69 | NA | -7.84 |
| AP Pharma Inc. (APPA) | -2.08 | 29.5M | NA | -182.47 | NA | NA | 21.36 | NA | -11.12 |
| Keryx Biopharmaceuticals Inc. (KERX) | -1.35 | 104.8M | 26.07 | 39.77 | NA | NA | 6.95 | 77.27 | 12.79 |
| Sanofi-Aventis (SNY) | -0.94 | 95.8B | NA | NA | 3.90 | NA | NA | 28.68 | NA |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -0.43 | 195.8M | NA | -38.76 | NA | NA | 2.37 | -119.22 | 12.74 |
| Merck & Co. Inc. (MRK) | -0.37 | 68.7B | 8.56 | 37.90 | 0.80 | NA | 3.00 | 56.60 | 16.40 |
| Pfizer Inc. (PFE) | -0.35 | 114.5B | 14.09 | NA | 3.80 | NA | 1.82 | 24.77 | NA |
| Abbott Laboratories (ABT) | -0.17 | 79.7B | 13.95 | NA | 3.10 | NA | 4.01 | 19.07 | NA |
| Avigen Inc. (AVGN) | 0.00 | 43.3M | NA | -39.35 | NA | NA | 1.10 | NA | -37.98 |
| China Aoxing Pharmaceutical Co (CAXG.OB) | 0.00 | 113.7M | NA | -10.83 | NA | NA | 4.17 | -77.00 | -42.14 |
| Neurologix Inc. (NRGX.OB) | 0.00 | 18.1M | NA | -60.49 | NA | NA | 1.59 | NA | -13.86 |
| Novogen Limited (NVGN) | 0.00 | 52.1M | NA | -69.63 | NA | NA | 2.41 | -208.88 | -15.08 |
| Quick-Med Technologies Inc. (QMDT.OB) | 0.00 | 24.2M | NA | NA | NA | NA | NA | NA | -161.09 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.4M | NA | NA | NA | NA | NA | NA | -39.71 |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 0.5M | NA | -260.11 | NA | NA | 2.67 | -185.00 | -1.47 |
| AstraZeneca plc (AZN) | 0.11 | 65.2B | 9.03 | 40.66 | 2.60 | NA | 3.36 | 25.79 | 40.33 |
| CPEX Pharmaceuticals, Inc. (CPEX) | 0.11 | 23.2M | NA | -10.81 | NA | NA | 0.99 | -26.92 | -94.31 |
| GlaxoSmithKline plc (GSK) | 0.15 | 102.7B | 12.74 | 58.25 | 4.80 | NA | 6.66 | 19.75 | 34.63 |
| Eli Lilly & Co. (LLY) | 0.20 | 39.6B | NA | -1.83 | 5.70 | NA | 4.00 | 16.93 | 191.62 |
| Novartis AG (NVS) | 0.42 | 119.9B | 15.81 | 14.59 | 3.30 | NA | 2.25 | 18.58 | 53.07 |
| Johnson & Johnson (JNJ) | 0.53 | 166.2B | 13.17 | NA | 3.30 | NA | 3.59 | 22.18 | NA |
| Skystar Bio Pharmaceutical Com (SKBI) | 0.58 | 66.1M | 5.92 | 25.29 | NA | NA | 2.48 | -1.87 | -23.22 |
| Bristol-Myers Squibb Co. (BMY) | 0.62 | 44.8B | 11.71 | 27.57 | 5.50 | NA | 3.09 | 17.61 | 35.97 |
| Impax Laboratories Inc. (IPXL) | 0.72 | 599.7M | 92.86 | 3.88 | NA | NA | 3.45 | 5.16 | 26.89 |
| Aceto Corp. (ACET) | 1.04 | 143.3M | 16.93 | 6.12 | 3.40 | NA | 1.01 | 1.41 | 6.07 |
| Javelin Pharmaceuticals, Inc. (JAV) | 1.63 | 75.8M | NA | -219.04 | NA | NA | NA | NA | -12.38 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 1.93 | 383.5M | NA | -91.80 | NA | NA | 2.94 | NA | -24.05 |
| Evotec AG (EVTC) | 2.00 | 721.6M | NA | -51.72 | NA | NA | NA | -81.60 | NA |
| Omeros Corporation (OMER) | 2.24 | 20.2M | NA | NA | NA | NA | NA | NA | -6.36 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 4.71 | 53.9M | NA | -102.39 | NA | NA | 5.30 | NA | -28.03 |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | 10.00 | 16.8M | NA | NA | NA | NA | NA | NA | -23.38 |
| China Pharma Holdings, Inc. (CPHI) | NA | NA | NA | 25.46 | NA | NA | NA | 31.51 | NA |
| HST Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Medizone International Inc. (MZEI.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |